Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.
Sign Up to like & getrecommendations! Published in 2017 at "Biochimie"
DOI: 10.1016/j.biochi.2017.01.001
Abstract: The variable manifestation of phenotypes that occur in patients with neurofibromatosis type 1 (NF1) includes benign and malignant neurocutaneous tumors for which no adequate treatment exists. Cell-based screening of known bioactive compounds library identified the… read more here.
Keywords: biochemical compound; medium throughput; compound screening; throughput biochemical ... See more keywords